Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim.
about
PEGylation of Interferon-β-1aPegylated granulocyte colony stimulating factor versus non-pegylated granulocyte colony stimulating factor for patients after hematopoietic stem cell transplantationPegylated granulocyte colony stimulating factor versus non-pegylated granulocyte colony stimulating factor for peripheral stem cell mobilizationTherapeutic alpha-interferons protein: structure, production, and biosimilar.A glycosylated recombinant human granulocyte colony stimulating factor produced in a novel protein production system (AVI-014) in healthy subjects: a first-in human, single dose, controlled study.Delivery of Flt3 ligand (Flt3L) using a poloxamer-based formulation increases biological activity in mice.Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans.SIV replication in the infected rhesus macaque is limited by the size of the preexisting TH17 cell compartment.Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trialDiabetes impairs stem cell and proangiogenic cell mobilization in humans.Effectiveness of cytopenia prophylaxis for different filgrastim and pegfilgrastim schedules in a chemotherapy mouse model.Safety and tolerability of Peg-grafeel™, a pegfilgrastim, for the prophylactic treatment of chemotherapy-induced neutropenia and febrile neutropenia: A prospective, observational, postmarketing surveillance study in India.Pegylated granulocyte-colony stimulating factor versus non-pegylated granulocyte-colony stimulating factor for peripheral blood stem cell mobilization: A systematic review and meta-analysis.Site of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway.Sensory neuropathy hampers nociception-mediated bone marrow stem cell release in mice and patients with diabetes.Development of a new G-CSF product based on biosimilarity assessment.Relationship between absolute neutrophil count profiles and pharmacokinetics of DA-3031, a pegylated granulocyte colony-stimulating factor (pegylated-G-CSF): a dose block-randomized, double-blind, dose-escalation study in healthy subjects.Pharmacokinetic and pharmacodynamic properties of a new long-acting granulocyte colony-stimulating factor (HM10460A) in healthy volunteers.
P2860
Q22241420-CCC4C66B-FCBD-4977-8775-5BBF5AAB7AE9Q24201099-A22BD645-7B49-45CF-A125-21F44FCB0E7AQ24201219-6B114760-2E95-49D4-B0DC-52B1EF359157Q30361968-2879FCE3-96F8-4AF9-A11C-D6DC9314B0F3Q33403643-6C326819-08F8-4046-BF20-79ACC83B2E81Q34183401-5F3104C7-5B13-4C60-9236-AFBB7F1E911BQ36427261-D9B36DE5-22D4-4759-B164-8350B6161C31Q36462335-D3A59C65-FDFB-4267-88A2-40111E85E108Q36579055-1A570BB2-01EA-4EA7-9174-E02AE86D8BD0Q36720330-935A189C-17B3-4951-AE61-356EFE0FCC6EQ37303210-0408D6B2-22D0-49E1-9189-FB22D2EAE508Q37737017-9FFE4A31-F276-47EE-8C33-718F721036FEQ38796594-38EC499A-0650-4A9F-9160-3ACFF3203062Q40481236-BA0C7DBA-8C78-4D06-8441-FC0BBBDD4220Q41553791-FB25DB80-5DA2-42C8-901E-993D6DE0141BQ42643304-7874071E-F33D-477E-813D-1272450EF1E7Q44019603-8190537A-FD36-4F91-A56E-ED10048D0F9BQ44555003-77754F0B-22FB-4260-847F-F02626B49C28
P2860
Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pharmacodynamics and pharmacok ...... ple daily doses of filgrastim.
@ast
Pharmacodynamics and pharmacok ...... ple daily doses of filgrastim.
@en
Pharmacodynamics and pharmacok ...... s pegylated human G-CSF mutant
@nl
type
label
Pharmacodynamics and pharmacok ...... ple daily doses of filgrastim.
@ast
Pharmacodynamics and pharmacok ...... ple daily doses of filgrastim.
@en
Pharmacodynamics and pharmacok ...... s pegylated human G-CSF mutant
@nl
prefLabel
Pharmacodynamics and pharmacok ...... ple daily doses of filgrastim.
@ast
Pharmacodynamics and pharmacok ...... ple daily doses of filgrastim.
@en
Pharmacodynamics and pharmacok ...... s pegylated human G-CSF mutant
@nl
P2093
P2860
P356
P1476
Pharmacodynamics and pharmacok ...... iple daily doses of filgrastim
@en
P2093
Capdeville R
Edwards DJ
van Der Auwera P
P2860
P304
P356
10.1002/AJH.1052
P577
2001-04-01T00:00:00Z